PLEGRIDY 125 micrograms, solution for injection in a pre-filled syringe 2 syringes of 0.5 ml, CIP 3400927949326
Active ingredients: Peginterferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 0.5 ml, CIP 3400927949326intramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PLEGRIDY 125 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 2 seringue(s) préremplie(s) en verre de 0,5 ml (voie sous-cutanée)
- Marketing authorisation holder
- BIOGEN NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Oct 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66988648CIP72794932CIP133400927949326Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PÉGINTERFÉRON BÊTA-1Asolution | 125 microgrammes · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.